RxDoctor Payments Data

John Williams, MD

Family Medicine · Lynchburg, VANPI 1619959293

Payments from drug & device makers

$11,902in general payments, 2019–2025

Across 860 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • Amgen$786
  • Pfizer$667
  • GSK$622
  • plus $5K from 43 others

What the payments were for

  • Food & beverage$11,882100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,902 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$8,932
Medicare patients
84
Services billed
521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$24,103
JanuviaSitagliptin Phosphate24$20,298
JardianceEmpagliflozin12$19,547
XareltoRivaroxaban11$11,437
Atorvastatin Calcium242$1,793
Ezetimibe66$1,491
Lisinopril217$1,239
Tamsulosin Hcl71$1,127
SynthroidLevothyroxine Sodium15$1,042
Omeprazole111$1,021
Simvastatin116$948
Rosuvastatin Calcium56$837
Potassium Chloride43$781
Levothyroxine Sodium86$760
Nifedipine ErNifedipine18$683

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$667$24,10314 claims
MerckJanuvia$180$20,29824 claims
Boehringer IngelheimJardiance$578$19,54712 claims
Johnson & JohnsonXarelto$411$11,43711 claims
AbbVieSynthroid$1,350$1,04215 claims
Almatica Pharma LLCSertraline Hcl$19$27924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Lynchburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →